These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36748953)

  • 1. Targeting lipid metabolism with natural products: A novel strategy for gastrointestinal cancer therapy.
    Guo C; Zhang L; Zhao M; Ai Y; Liao W; Wan L; Liu Q; Li S; Zeng J; Ma X; Tang J
    Phytother Res; 2023 May; 37(5):2036-2050. PubMed ID: 36748953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pull the plug: Anti-angiogenesis potential of natural products in gastrointestinal cancer therapy.
    Ai Y; Zhao Z; Wang H; Zhang X; Qin W; Guo Y; Zhao M; Tang J; Ma X; Zeng J
    Phytother Res; 2022 Sep; 36(9):3371-3393. PubMed ID: 35871532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy.
    Tewari D; Patni P; Bishayee A; Sah AN; Bishayee A
    Semin Cancer Biol; 2022 May; 80():1-17. PubMed ID: 31866476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Inonotus obliquus (Fr.) Pilat extract on the regulation of glycolipid metabolism via PI3K/Akt and AMPK/ACC pathways in mice.
    Zhang Z; Liang X; Tong L; Lv Y; Yi H; Gong P; Tian X; Cui Q; Liu T; Zhang L
    J Ethnopharmacol; 2021 Jun; 273():113963. PubMed ID: 33640441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytochemicals and Nanoparticles in the Modulation of PI3K/Akt/mTOR Kinases and its Implications in the Development and Progression of Gastrointestinal Cancers: A Review of Preclinical and Clinical Evidence.
    Narayanankutty A; Nambiattil S; Mannarakkal S
    Recent Pat Anticancer Drug Discov; 2023; 18(3):307-324. PubMed ID: 35670354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
    Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G
    Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway.
    Chu H; Du C; Yang Y; Feng X; Zhu L; Chen J; Yang F
    Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3K-AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds.
    Yuan Y; Long H; Zhou Z; Fu Y; Jiang B
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory Potential of Dietary Nutraceuticals on Cellular PI3K/Akt Signaling: Implications in Cancer Prevention and Therapy.
    Narayanankutty A
    Curr Top Med Chem; 2021; 21(20):1816-1831. PubMed ID: 34279200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways.
    Huang J; Feng W; Li S; Tang H; Qin S; Li W; Gong Y; Fang Y; Liu Y; Wang S; Guo Y; Xu Z; Shen Q
    Curr Pharm Des; 2021; 27(4):565-574. PubMed ID: 32988344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting SREBP-1-driven lipid metabolism to treat cancer.
    Guo D; Bell EH; Mischel P; Chakravarti A
    Curr Pharm Des; 2014; 20(15):2619-26. PubMed ID: 23859617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central role of SREBP-2 in the pathogenesis of osteoarthritis.
    Kostopoulou F; Gkretsi V; Malizos KN; Iliopoulos D; Oikonomou P; Poultsides L; Tsezou A
    PLoS One; 2012; 7(5):e35753. PubMed ID: 22662110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy.
    Chamcheu JC; Roy T; Uddin MB; Banang-Mbeumi S; Chamcheu RN; Walker AL; Liu YY; Huang S
    Cells; 2019 Jul; 8(8):. PubMed ID: 31370278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural products attenuate PI3K/Akt/mTOR signaling pathway: A promising strategy in regulating neurodegeneration.
    Fakhri S; Iranpanah A; Gravandi MM; Moradi SZ; Ranjbari M; Majnooni MB; Echeverría J; Qi Y; Wang M; Liao P; Farzaei MH; Xiao J
    Phytomedicine; 2021 Oct; 91():153664. PubMed ID: 34391082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy.
    Xu Z; Han X; Ou D; Liu T; Li Z; Jiang G; Liu J; Zhang J
    Appl Microbiol Biotechnol; 2020 Jan; 104(2):575-587. PubMed ID: 31832711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
    Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
    World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
    Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
    Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Akt-SREBP nexus: cell signaling meets lipid metabolism.
    Krycer JR; Sharpe LJ; Luu W; Brown AJ
    Trends Endocrinol Metab; 2010 May; 21(5):268-76. PubMed ID: 20117946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase Cε Regulates Prostate Cancer Lipid Metabolism and Proliferation by Targeting AMP-Activated Protein Kinase (AMPK)/Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Signaling Pathway.
    Zheng Y; Jin J; Gao Y; Luo C; Wu X; Liu J
    Med Sci Monit; 2020 Jul; 26():e924328. PubMed ID: 32696762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inhibiting PI3K-Akt-mTOR pathway on lipid metabolism homeostasis in goose primary hepatocytes.
    Liu DD; Han CC; Wan HF; He F; Xu HY; Wei SH; Du XH; Xu F
    Animal; 2016 Aug; 10(8):1319-27. PubMed ID: 26956906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.